Kerry Holford

Stock Analyst at Berenberg

(1.87)

# 3,266

Out of 5,245 analysts

10

Total ratings

42.86%

Success rate

9.51%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - General

Stocks Rated by Kerry Holford

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	NVO Novo Nordisk	Upgrades: Buy	n/a	$44.96	-	1	Sep 17, 2025
	LLY Eli Lilly and Company	Downgrades: Hold	$970 → $830	$1,065.00	-22.07%	9	Sep 17, 2025

Novo Nordisk

Sep 17, 2025

Upgrades: Buy

Price Target: n/a

Current: $44.96

Upside: -

Eli Lilly and Company

Sep 17, 2025

Downgrades: Hold

Price Target: $970 → $830

Current: $1,065.00

Upside: -22.07%